A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

Weill Cornell Medicine-New York Presbyterian Hospital, New York

Memorial Sloan Kettering Cancer Center, New York

Weill Cornell Medicine Sandra and Edward Meyer Cancer Center, New York

Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York

Medical Oncology Hematology Consultants (MOHC) - Helen F. Graham Cancer Center, Newark

Maryland Oncology Hematology, Columbia

Virginia Cancer Specialists, Fairfax

Shenandoah Oncology, Winchester

Florida Cancer Specialist North, St. Petersburg

Virginia Oncology Associates - Brock Cancer Center, Norfolk

Cancer Care Centers of Brevard, Palm Bay

Florida Cancer Specialist South, Fort Myers

Sarah Cannon Research Institute at Tennessee Oncology, Nashville

Oncology Hematology Care - Eastgate, Cincinnati

Sarah Cannon Research Institute at Tennessee Oncology, Cincinnati

Rogel Cancer Center, University of Michigan Medicine, Ann Arbor

Minnesota Oncology, Minneapolis

Illinois Cancer Specialists, Arlington Heights

Nebraska Medicine-Nebraska Medical Center, Omaha

Texas Oncology, Carrollton

TxO - Denison Cancer Center, Denison

Baylor Charles A. Sammons Cancer Center, Dallas

Northeast Texas Cancer & Research Institute, Tyler

The Center for Cancer & Blood Disorders: Fort Worth, Fort Worth

HonorHealth, Scottsdale

Comprehensive Cancer Centers of Nevada - Summerlin Medical Center II*, Las Vegas

USC Norris Comprehensive Cancer Center, Los Angeles

UCLA Health - Santa Monica Cancer Care, Santa Monica

USC Norris Oncology, Newport Beach

Swedish Cancer Institute, Seattle

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

John Theurer Cancer Center at Hackensack, Hackensack

Atlantic Health Systems, Morristown, Morristown

Overlook Medical Center, Summit

Lifespan, Providence